| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 18,114 | 19,117 | 18,283 | 18,157 | | Cost of Revenue | 8,278 | 8,453 | 7,944 | 7,797 | | | Gross Profit | 9,836 | 10,664 | 10,339 | 10,360 | | | Operating Expenses | | Research Development | 1,542 | 1,441 | 1,412 | 1,973 | | Selling General and Administrative | 9,462 | 9,887 | 10,061 | 16,638 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,168) | (664) | (1,134) | (8,251) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (38) | 255 | 141 | (323) | | Earnings Before Interest And Taxes | (1,206) | (409) | (993) | (8,574) | | Interest Expense | 551 | 399 | 233 | 256 | | Income Before Tax | (1,757) | (808) | (1,226) | (8,830) | | Income Tax Expense | 210 | 280 | 436 | 630 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,967) | (1,088) | (1,662) | (9,460) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,967) | (1,088) | (1,662) | (9,460) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,967) | ($1,088) | ($1,662) | ($9,460) |
|
0.02% Nasdaq 
0.72%
Income Statement
